Recognized for Continued Market Leadership in Parenteral and Nutrition/Solutions
Bethlehem, PA — (June 4, 2009) — B. Braun Medical Inc. (B. Braun) today announced that it had received two 2009 GHX Best in Class Awards for achieving the highest year-over-year market share growth for distributed products in the Parenteral and Solutions/Nutritionals product categories for the 2008 calendar year.
B. Braun was among 30 leading medical-surgical product manufacturers recognized by GHX in five market segments and 35 product categories, ranging from cardiovascular devices to skin-care products. Winners were determined using GHX Market Intelligence reports that analyze national distributed sales transaction data.
“We are proud of our contribution to advancing patient outcomes with our infusion therapy products and services which add to the growth of the market,” said Caroll H. Neubauer, Chairman and CEO of B. Braun Medical Inc. “Our success in Parenteral and Solutions/Nutritionals, like all of our products, is built on delivering products that meet customer needs and supporting them with outstanding educational programs and customer service.”
This is the second consecutive year GHX awarded B. Braun its Best in Class Awards in the Parenteral and Solutions/Nutritionals product categories.
“We are extremely pleased to honor B. Braun for its leadership in the Parenteral and Solutions/Nutritionals product categories,” said Ed McCauley, general manager, GHX Market Intelligence. “Despite the down economy, B. Braun grew 7.37 percent in the Parenteral category in 2008 while the overall market segment grew 7.45 percent, and 22.17 percent in the Solutions/Nutritionals category in 2008 while the overall market segment grew 16.4 percent.”
With information provided by 27 of the nation’s leading distributors, GHX Market Intelligence tracks and reports on more than $34 billion of distributed sales for medical-surgical and clinical laboratory supplies and devices. It is the only comprehensive source for accurate, detailed and timely data for the acute and alternate site healthcare markets, containing geographically relevant and competitive market share, size and average selling price reporting down to the three-digit ZIP code level.
About B. Braun
B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company’s “Sharing Expertise®” philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.
Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at email@example.com or visit B. Braun at www.bbraunusa.com.
As the business hub for healthcare, GHX enables healthcare providers and suppliers in North America and Europe to reduce costs and improve margins by automating processes, reducing operating expenses and increasing knowledge-based decision making. Products and services include trading partner connectivity, order and contract management and validation, data synchronization, sales force automation and business intelligence. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B Braun Medical Inc.; Becton, Dickinson & Co.; Boston Scientific Corp.; Cardinal Health, Inc.; Covidien; C.R. Bard, Inc.; Fisher Scientific International, Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; University HealthSystem Consortium; and VHA Inc. For more information, visit www.ghx.com.